VITRUVIAS THERAPEUTICS INC
VITRUVIAS THERAPEUTICS INC appears in FDA public data with 1 recall — including 1 Class I (most serious) —, 0 510(k) clearances, 1 FDA inspection, and 0 compliance actions on record. Its most recent recall (D-0866-2026, Class I) was initiated on August 21, 2026.
Summary
- Total Recalls
- 1 (1 Class I)
- 510(k) Clearances
- 0
- Inspections
- 1
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0866-2026 | Class I | Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyroni | August 21, 2026 |